Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inamed To Spurn Medicis? Aesthetics Firm Weighs Allergan’s $3.2 Bil. Offer

This article was originally published in The Gray Sheet

Executive Summary

Inamed is considering a $3.2 bil. unsolicited offer from pharmaceutical specialty firm Allergan after determining that the bid is likely superior to its planned merger with Medicis, the firm announced Nov. 16
Advertisement

Related Content

Candela Sees Beaming Future In Family Practice As Stock Jumps 54%
Inamed’s Board Embraces Allergan’s Offer After Dissolving Deal With Medicis
Inamed’s Board Embraces Allergan’s Offer After Dissolving Deal With Medicis
Candela Sees Beaming Future In Family Practice As Stock Jumps 54%
Allergan Tightens The Screws On Inamed Deal, While Mentor Bids On Medicis
Allergan Tightens The Screws On Inamed Deal, While Mentor Bids On Medicis
Advertisement
UsernamePublicRestriction

Register

MT022919

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel